Compare drug alternatives
Ubrelvy® Alternatives
Ubrelvy®
(ubrogepant)
Ubrelvy
-
Migraine
- Emgality®
- Vyepti®
- Ajovy®
- Nurtec ODT®
- Qulipta®
Prescription Only
Ubrelvy is a medication that adults can use to treat acute migraine attacks. It works by blocking CGRP, a protein believed to contribute to migraine attacks by causing pain, blood vessel dilation, and inflammation. Ubrelvy is well-tolerated, with less than 5% of individuals reporting side effects such as nausea, somnolence, and dry mouth. Ubrelvy does not prevent migraines.
Ubrelvy is FDA approved for the following indications: Migraine.
Aimovig®
(Erenumab)
Aimovig
-
Migraine
- Emgality®
- Vyepti®
- Ajovy®
- Nurtec ODT®
- Qulipta®
Prescription Only
Aimovig is a prescription medication that adults can self-inject once a month under the skin to prevent migraine headaches. The most common side effects are injection site reactions and constipation. However, there are no reported instances of drug interactions with Aimovig.
Aimovig is FDA approved for the following indications: Migraine prevention.
Dosage & Administration
Administration
Oral
Subcutaneous
Dosing
50 mg or 100 mg as needed. Maximum daily dose: 200 mg. Severe Hepatic or Severe Renal Impairment: 50 mg.
70 mg once monthly or 140 mg once monthly (for some patients)
Latin Shorthand
50 mg PRN or 100 mg PNR. Severe Renal Impairment: 50mg.
70 mg/mo or 140 mg/mo
Financial Assistance
Copay
$0
$5
Annual Cap
Maximum savings of $50 per pill for up to 13 prescription fills.
Patient specific maximum benefit.
Assistance Expiration
13 prescription fills
Calendar year
Generics
No lower-cost generic available
No lower-cost generic available